# Boston Scientific Corporation (NYSE: BSX), Marlborough, MA – FDA Inspections

Source: https://www.keypedia.com/companies/boston-scientific-corporation/7b03f40b-d516-4bcb-9702-929c6f485000

> Inspection records and compliance data for Boston Scientific Corporation in Marlborough, Massachusetts. 14 FDA inspections on record, 2 Form 483s, last inspected November 26, 2024. Publicly traded as NYSE: BSX.

---

## Details

- Name: Boston Scientific Corporation
- FEI Number: 3005099803
- Address Line 1: 100 Boston Scientific Way
- City: Marlborough
- State: Massachusetts
- Zip Code: 01752
- Country Name: United States
- Address: 100 Boston Scientific Way, Marlborough, Massachusetts 01752, United States
- Country: United States

## Stock

- Stock ticker: BSX
- Exchange: NYSE
- Share price: $44.61
- Market cap: $64.7B
- Price as of: November 6, 2026

## Related Documents

- [483 - Boston Scientific Corporation - 2024-11-26](https://www.keypedia.com/records/483/boston-scientific-corporation/3f333115-bd96-40e1-9782-0b2055c37911) — source: FDA, date: November 26, 2024
- [FDA Inspection 1246067 - Boston Scientific Corporation - 2024-11-26](https://www.keypedia.com/records/fda_inspections/boston-scientific-corporation/eefde949-c3da-46ba-b8c3-50e3a653a7d0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 26, 2024
- FDA Inspection 1246067 - Boston Scientific Corporation - 2024-11-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 26, 2024
- FDA Inspection 1196120 - Boston Scientific Corporation - 2023-01-13 — source: FDA, date: January 13, 2023
- FDA Inspection 1130716 - Boston Scientific Corporation - 2019-06-07 — source: FDA, date: June 7, 2019
- FDA Inspection 1117032 - Boston Scientific Corporation - 2019-05-29 — source: FDA, date: May 29, 2019
- FDA Inspection 1072267 - Boston Scientific Corporation - 2018-10-31 — classification: No Action Indicated (NAI), source: FDA, date: October 31, 2018
- FDA Inspection 1072267 - Boston Scientific Corporation - 2018-10-31 — classification: No Action Indicated (NAI), source: FDA, date: October 31, 2018
- [FDA Inspection 1068733 - Boston Scientific Corporation - 2018-09-20](https://www.keypedia.com/records/fda_inspections/boston-scientific-corporation/c11503ac-36c1-48a4-8f43-d0f8a6662d6e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 20, 2018
- [FDA Inspection 1053467 - Boston Scientific Corporation - 2017-12-06](https://www.keypedia.com/records/fda_inspections/boston-scientific-corporation/42303a83-ed37-40b6-9fd3-3b67789203d9) — source: FDA, date: December 6, 2017
- FDA Inspection 1051801 - Boston Scientific Corporation - 2017-09-20 — source: FDA, date: September 20, 2017

## Related Companies

- [AngioDynamics, Inc.](https://www.keypedia.com/companies/angiodynamics-inc/1bc90c7f-6a45-49ef-a2a5-fc38418e84aa)
- [Ventana Medical Systems, Inc.](https://www.keypedia.com/companies/ventana-medical-systems-inc/fbee7b78-8ed8-4956-853d-aae637e77eab)
- [Omega Medical Imaging, Inc.](https://www.keypedia.com/companies/omega-medical-imaging-inc/74d04b67-394a-442a-b4f2-08d3f58760c3)
- [Abbott](https://www.keypedia.com/companies/abbott/b7d5749c-5854-4f4a-ad2f-fd6002f0d9fe)
- [Physio-Control, Inc.](https://www.keypedia.com/companies/physio-control-inc/cd3b1656-c525-4cfe-a3f2-d32143e20c7c)
- [Microgenics Corporation](https://www.keypedia.com/companies/microgenics-corporation/afa7631f-c7cb-467d-8c9b-c3f4cc83cc65)
- [Focus Medical, LLC](https://www.keypedia.com/companies/focus-medical-llc/dc3869e7-ddde-4fb3-bf78-b606df8ae023)
- [DSM Biomedical, Inc.](https://www.keypedia.com/companies/dsm-biomedical-inc/7a6db46d-6f3e-4e92-8fde-1d4f124bdc5e)
- [Invacare Corporation](https://www.keypedia.com/companies/invacare-corporation/ce6ef1ad-105f-4eb0-b2a1-46530b41907a)
- [Xintec Corp](https://www.keypedia.com/companies/xintec-corp/68cff15b-7e97-469a-bba5-602f16256f3f)

## Related Officers

- [Sara M. Onyango](https://www.keypedia.com/people/sara-m-onyango/643c6ad3-9747-4bc2-9e8e-72f97b11e659)